首页> 外文OA文献 >Real-life data on the efficacy and safety of ombitasvir/paritaprevir/ritonavir + dasabuvir +ribavirin in the patients with genotype 1 chronic hepatitis C virus infection in Serbia

【2h】

Real-life data on the efficacy and safety of ombitasvir/paritaprevir/ritonavir + dasabuvir +ribavirin in the patients with genotype 1 chronic hepatitis C virus infection in Serbia

机译：关于塞尔维亚基因型1慢性丙型肝炎病毒感染患者患者患者患者患者的疗效和安全性的现实生活数据

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Jasmina Simonovic-Babic; Ksenija Bojovic; Milotka Fabri; Tatjana Cvejic; Petar Svorcan; Darko Nozic; Maja Jovanovic; Ranko Skrbic; Milos Stojiljkovic; Zeljko Mijailovic;
展开▼
作者单位

展开▼
年度 2019
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Real-life data on the efficacy and safety of ombitasvir/paritaprevir/ritonavir + dasabuvir +ribavirin in the patients with genotype 1 chronic hepatitis C virus infection in Serbia [J] . Simonovi?-Babi? Jasmina, Bojovi? Ksenija, Fabri Milotka, Vojnosanitetski Pregled . 2019,第5期

机译：ombitasvir / paritaprevir / ritonavir + dasabuvir + ribavirin在基因型1型慢性丙型肝炎病毒感染塞尔维亚患者中的疗效和安全性的现实数据
2. Efficacy and safety of ombitasvir/paritaprevir/ritonavir and dasabuvir with low‐dose ribavirin in patients with chronic hepatitis C virus genotype 1a infection without cirrhosis [J] . Poordad Fred, Sedghi Shahriar, Pockros Paul J., Journal of viral hepatitis. . 2019,第8期

机译：慢性丙基肝炎病毒基因型1A感染患者慢性丙型肝炎病毒基因型1A感染患者的疗效和安全性的疗效和安全性和Dasbuvir
3. Efficacy and Safety of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With or Without Ribavirin in Patients With Chronic Hepatitis C Virus Genotype 1 Infection Receiving Opioid Substitution Therapy: A Post Hoc Analysis of 12 Clinical Trials [J] . Jason Grebely, Massimo Puoti, Heiner Wedemeyer, Open Forum Infectious Diseases . 2018,第11期

机译：Ombitasvir / Paritaprevir / Ritonavir和Dasabuvir联合或不联合利巴韦林在接受阿片类药物替代治疗的慢性丙型肝炎病毒基因型1感染患者中的疗效和安全性：对12项临床试验的事后分析
4. DIFFERENTIAL HUMORAL RESPONSE OF GENOTYPE IB HEPATITIS C VIRUS F PROTEIN BETWEEN CHRONIC AND RECOVERED INFECTIONS [C] . Deng Xiaozhao, Kong Jing, Chu Chunli, Progress on post-genome technologies and modern natural products . 2011

机译：慢性感染和康复感染之间基因型IB型肝炎C病毒F蛋白的差异性尿液反应
5. Population pharmacokinetics and efficacy of ribavirin in patients with chronic hepatitis C genotype 1 infection. [D] . Jin, Runyan. 2010

机译：利巴韦林在慢性丙型肝炎基因型1感染患者中的群体药代动力学和功效。
6. Efficacy and Safety of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With or Without Ribavirin in Patients With Chronic Hepatitis C Virus Genotype 1 Infection Receiving Opioid Substitution Therapy: A Post Hoc Analysis of 12 Clinical Trials [O] . Jason Grebely, Massimo Puoti, Heiner Wedemeyer, 2018

机译：Ombitasvir / Paritaprevir / Ritonavir和Dasabuvir联合或不联合利巴韦林在接受阿片类药物替代治疗的慢性丙型肝炎病毒基因型1感染患者中的疗效和安全性：对12项临床试验的事后分析
7. Efficacy and safety of ombitasvir/paritaprevir/ritonavir and dasabuvir with low‐dose ribavirin in patients with chronic hepatitis C virus genotype 1a infection without cirrhosis [O] . Fred Poordad, Shahriar Sedghi, Paul J. Pockros, 2019

机译：慢性丙基肝炎病毒基因型1A感染患者慢性丙基肝炎病毒基因型1A感染的疗效和Dasabuvir和Dasbuvir的疗效和安全性

Real-life data on the efficacy and safety of ombitasvir/paritaprevir/ritonavir + dasabuvir +ribavirin in the patients with genotype 1 chronic hepatitis C virus infection in Serbia

著录项

引文网络

相似文献

相关主题

期刊订阅